BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21153382)

  • 1. PET imaging of αvβ3 expression in cancer patients.
    Beer AJ; Schwaiger M
    Methods Mol Biol; 2011; 680():183-200. PubMed ID: 21153382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of integrin alphavbeta3 expression.
    Beer AJ; Schwaiger M
    Cancer Metastasis Rev; 2008 Dec; 27(4):631-44. PubMed ID: 18523730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.
    Beer AJ; Grosu AL; Carlsen J; Kolk A; Sarbia M; Stangier I; Watzlowik P; Wester HJ; Haubner R; Schwaiger M
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6610-6. PubMed ID: 18006761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.
    Beer AJ; Haubner R; Sarbia M; Goebel M; Luderschmidt S; Grosu AL; Schnell O; Niemeyer M; Kessler H; Wester HJ; Weber WA; Schwaiger M
    Clin Cancer Res; 2006 Jul; 12(13):3942-9. PubMed ID: 16818691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality tumor imaging targeting integrin alphavbeta3.
    Cai W; Sam Gambhir S; Chen X
    Biotechniques; 2005 Dec; 39(6 Suppl):S14-25. PubMed ID: 20158499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism.
    Metz S; Ganter C; Lorenzen S; van Marwick S; Herrmann K; Lordick F; Nekolla SG; Rummeny EJ; Wester HJ; Brix G; Schwaiger M; Beer AJ
    J Nucl Med; 2010 Nov; 51(11):1691-8. PubMed ID: 20956471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in PET myocardial perfusion imaging: F-18 labeled tracers.
    Rischpler C; Park MJ; Fung GS; Javadi M; Tsui BM; Higuchi T
    Ann Nucl Med; 2012 Jan; 26(1):1-6. PubMed ID: 22069195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.
    Schnell O; Krebs B; Carlsen J; Miederer I; Goetz C; Goldbrunner RH; Wester HJ; Haubner R; Pöpperl G; Holtmannspötter M; Kretzschmar HA; Kessler H; Tonn JC; Schwaiger M; Beer AJ
    Neuro Oncol; 2009 Dec; 11(6):861-70. PubMed ID: 19401596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How many PET tracers do we need?
    Schwaiger M; Wester HJ
    J Nucl Med; 2011 Dec; 52 Suppl 2():36S-41S. PubMed ID: 22144553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
    Chakravarty R; Chakraborty S; Dash A
    Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD.
    Haubner R; Weber WA; Beer AJ; Vabuliene E; Reim D; Sarbia M; Becker KF; Goebel M; Hein R; Wester HJ; Kessler H; Schwaiger M
    PLoS Med; 2005 Mar; 2(3):e70. PubMed ID: 15783258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Shao T; Chen Z; Belov V; Wang X; Rwema SH; Kumar V; Fu H; Deng X; Rong J; Yu Q; Lang L; Lin W; Josephson L; Samir AE; Chen X; Chung RT; Liang SH
    J Hepatol; 2020 Jul; 73(1):161-169. PubMed ID: 32145257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Integrin α
    Iagaru A
    J Nucl Med; 2017 Oct; 58(10):1706. PubMed ID: 28280224
    [No Abstract]   [Full Text] [Related]  

  • 16. RGD-based PET tracers for imaging receptor integrin αv β3 expression.
    Cai H; Conti PS
    J Labelled Comp Radiopharm; 2013 May; 56(5):264-79. PubMed ID: 24285371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.
    Tateishi U; Oka T; Inoue T
    Curr Med Chem; 2012; 19(20):3301-9. PubMed ID: 22664242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric PET and MRI of myocardial damage after myocardial infarction: correlation of integrin αvβ3 expression and myocardial blood flow.
    Makowski MR; Rischpler C; Ebersberger U; Keithahn A; Kasel M; Hoffmann E; Rassaf T; Kessler H; Wester HJ; Nekolla SG; Schwaiger M; Beer AJ
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1070-1080. PubMed ID: 32970218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.
    Chen H; Niu G; Wu H; Chen X
    Theranostics; 2016; 6(1):78-92. PubMed ID: 26722375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of integrin α(V)β(3) expression using (68)Ga-RGD positron emission tomography in pediatric cerebral infarct.
    Choi H; Phi JH; Paeng JC; Kim SK; Lee YS; Jeong JM; Chung JK; Lee DS; Wang KC
    Mol Imaging; 2013 Jun; 12(4):213-7. PubMed ID: 23651498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.